![]() Pegsebrenatide structure
|
Common Name | Pegsebrenatide | ||
---|---|---|---|---|
CAS Number | 2243292-26-2 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C206H318N54O69S2(C2H4O)m+2n; m≈10; n≈20 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PegsebrenatidePegsebrenatide (NLY01) is a long-acting GLP-1R agonist. Pegsebrenatide has an extended half-life and favorable blood-brain barrier penetration. Pegsebrenatide can block A1 astrocyte transformation, reducing dopaminergic cell death, and improving motor symptoms in mouse models of PD[1]. |
Name | Pegsebrenatide |
---|
Description | Pegsebrenatide (NLY01) is a long-acting GLP-1R agonist. Pegsebrenatide has an extended half-life and favorable blood-brain barrier penetration. Pegsebrenatide can block A1 astrocyte transformation, reducing dopaminergic cell death, and improving motor symptoms in mouse models of PD[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C206H318N54O69S2(C2H4O)m+2n; m≈10; n≈20 |
---|